These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35980187)

  • 1. Repurposing the Ionophore, PBT2, for Treatment of Multidrug-Resistant Neisseria gonorrhoeae Infections.
    Jen FE; Edwards JL; El-Deeb IM; Walker MJ; von Itzstein M; Jennings MP
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0231821. PubMed ID: 35980187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A drug candidate for Alzheimer's and Huntington's disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides.
    Jen FE; El-Deeb IM; Zalucki YM; Edwards JL; Walker MJ; von Itzstein M; Jennings MP
    J Antimicrob Chemother; 2021 Oct; 76(11):2850-2853. PubMed ID: 34450628
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Jen FE; Everest-Dass AV; El-Deeb IM; Singh S; Haselhorst T; Walker MJ; von Itzstein M; Jennings MP
    ACS Infect Dis; 2020 Jan; 6(1):50-55. PubMed ID: 31697892
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.
    Stefanelli P
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):237-44. PubMed ID: 21342071
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
    Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance.
    Bohlmann L; De Oliveira DMP; El-Deeb IM; Brazel EB; Harbison-Price N; Ong CY; Rivera-Hernandez T; Ferguson SA; Cork AJ; Phan MD; Soderholm AT; Davies MR; Nimmo GR; Dougan G; Schembri MA; Cook GM; McEwan AG; von Itzstein M; McDevitt CA; Walker MJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30538186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neisseria gonorrhoeae and fosfomycin: Past, present and future.
    Tesh LD; Shaeer KM; Cho JC; Estrada SJ; Huang V; Bland CM; DiMondi VP; Potter AN; Hussein G; Bookstaver PB
    Int J Antimicrob Agents; 2015 Sep; 46(3):290-6. PubMed ID: 26145201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2.
    Harbison-Price N; Ferguson SA; Heikal A; Taiaroa G; Hards K; Nakatani Y; Rennison D; Brimble MA; El-Deeb IM; Bohlmann L; McDevitt CA; von Itzstein M; Walker MJ; Cook GM
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32188750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein.
    Chitsaz M; Booth L; Blyth MT; O'Mara ML; Brown MH
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technological Solutions to Address Drug-Resistant Neisseria gonorrhoeae.
    Bristow CC; Dong H; Klausner JD
    Emerg Infect Dis; 2016 May; 22(5):939-40. PubMed ID: 27088665
    [No Abstract]   [Full Text] [Related]  

  • 11. Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.
    De Oliveira DMP; Forde BM; Phan MD; Steiner B; Zhang B; Zuegg J; El-Deeb IM; Li G; Keller N; Brouwer S; Harbison-Price N; Cork AJ; Bauer MJ; Alquethamy SF; Beatson SA; Roberts JA; Paterson DL; McEwan AG; Blaskovich MAT; Schembri MA; McDevitt CA; von Itzstein M; Walker MJ
    mBio; 2022 Feb; 13(1):e0351721. PubMed ID: 35012353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Characterization of Emerging Bacterial Uropathogen Neisseria meningitidis, Which Was Misidentified as Neisseria gonorrhoeae by Nucleic Acid Amplification Testing.
    Sukhum KV; Jean S; Wallace M; Anderson N; Burnham CA; Dantas G
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33177123
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.
    Allan-Blitz LT; Humphries RM; Hemarajata P; Bhatti A; Pandori MW; Siedner MJ; Klausner JD
    Clin Infect Dis; 2017 May; 64(9):1268-1270. PubMed ID: 28034887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae.
    Yang F; Liu J; Gu Y; Jiao R; Yan J; Gao S; Lin X; van der Veen S
    Microbiol Spectr; 2022 Dec; 10(6):e0395222. PubMed ID: 36350125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
    Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
    J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose of cefodizime completely eradicated multidrug-resistant strain of Neisseria gonorrhoeae in urethritis and uterine cervicitis.
    Matsumoto T; Muratani T; Takahashi K; Ando Y; Sato Y; Kurashima M; Yokoo D; Ikuyama T; Shimokawa H; Yanai S
    J Infect Chemother; 2006 Apr; 12(2):97-9. PubMed ID: 16648949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
    Brunner A; Nemes-Nikodem E; Mihalik N; Marschalko M; Karpati S; Ostorhazi E
    BMC Infect Dis; 2014 Aug; 14():433. PubMed ID: 25098185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramoplanin as a novel therapy for
    Gestels Z; De Baetselier I; Abdellati S; Manoharan-Basil SS; Kenyon C
    J Med Microbiol; 2024 Jan; 73(1):. PubMed ID: 38214499
    [No Abstract]   [Full Text] [Related]  

  • 19. Sharp increase in ciprofloxacin resistance of
    Crucitti T; Belinga S; Fonkoua MC; Abanda M; Mbanzouen W; Sokeng E; Nzouankeu A
    Int J STD AIDS; 2020 May; 31(6):579-586. PubMed ID: 32316853
    [No Abstract]   [Full Text] [Related]  

  • 20. Is gentamicin a viable therapeutic option for treating resistant Neisseria gonorrhoeae in New South Wales?
    Armstrong BH; Limnios A; Lewis DA; Hogan T; Kundu R; Ray S; Shoushtari M; El Nasser J; Driscoll T; Lahra MM
    Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.